The Future of Vaccines: What We Learned at the First Annual Conference

The Michelson Medical Research Foundation and the Human Immunome Project (formerly Human Vaccines Project) hosted the first Annual Conference on the Future of Vaccine Development on June 27, 2018, at the USC Michelson Center for Convergent Bioscience.

The conference brought together leading scientists and researchers from around the world to discuss the latest advances in vaccines and to explore new ways to accelerate the development of vaccines against some of the world's most threatening diseases.

Featured speakers:

  • Dr. Gary K. Michelson, Founder and President of the Michelson Medical Research Foundation.

  • Ian Gust, AO, Chair of the Board of Directors at the Human Vaccines Project

  • Wayne Koff, PhD, President / CEO of the Human Vaccines Project

  • Steve A. Kay, Director of the USC Michelson Center for Convergent Bioscience

Learn more about the Michelson Prizes: Next Generation Grants

The Michelson Prizes: Next Generation Grants are $150,000 research grants given annually to support promising researchers applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases.

To learn more about the Michelson Prizes: Next Generation Grants, please visit michelsonmedical.org/initiatives/michelson-prizes-human-vaccines-project/.

Previous
Previous

Dr. Patricia Therese Illing: How Spliced Peptides Could Revolutionize Influenza Vaccines

Next
Next

Society for Brain Mapping and Therapeutics 2018 Humanitarian Award